Quantcast

News by region

FDA accepts sNDA filing for Allergan’s pneumonia drug

The U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for Allergan’s Avycaz (ceftazidime and avibactam) for priority review.

Posted in Approval, news, North America, Regions | Tagged , , , , | Leave a comment

Sanofi appoints new EVP Diabetes & Cardiovascular

Sanofi has appointed Stefan Oelrich as Executive Vice President Diabetes & Cardiovascular (DCV), effectively immediately.

Posted in Europe, news, Regions | Tagged , , | Leave a comment

Novartis’s Alcon introduces new innovations in cataract surgery at ESCRS 2017 annual congress

Alcon, a division of Novartis, will introduce Clareon, the intraocular lens (IOL) with the most advanced optic material available in an automated, disposable, pre-loaded delivery system, at the XXXV European Society of Cataract & Refractive Surgeons (ESCRS) congress taking place October 7 – 11 in Lisbon, Portugal.

Posted in Europe, news, Regions | Tagged , , , | Leave a comment

Eli Lilly in leadership chances

Eli Lilly has made certain leadership changes, promoting several experienced Lilly leaders to executive roles, effective in 2018.

Posted in news, North America, Regions | Tagged , | Leave a comment

FDA OK’s Eli Lilly’s breast cancer drug

The U.S. Food and Drug Administration has approved  Eli Lilly’s Verzenio (abemaciclib) to treat adult patients who have hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer that has progressed after taking therapy that alters a patient’s hormones (endocrine therapy).

Posted in Approval, news, North America, Regions | Tagged , , | Leave a comment

Novartis and UC Berkeley collaborate to tackle ‘undruggable’ disease targets

Novartis has joined forces with researchers from the University of California, Berkeley, to develop new technologies for the discovery of next-generation therapeutics, pursuing the vast number of disease targets in cancer and other illnesses that have eluded traditional small-molecule compounds and are considered “undruggable.”

Posted in Europe, news, North America, studies | Tagged , , , , | Leave a comment

Basilea Pharmaceutica in license agreement with Chinese drugmaker

Basilea Pharmaceutica has entered into a license agreement with Shenzhen China Resources Gosun Pharmaceutical Co., Ltd. (CR Gosun) for Basilea’s antibiotic Zevtera (ceftobiprole) in China, Hong Kong and Macao (the Territory).

Posted in Asia, news, Regions | Tagged , , | Leave a comment

Novo Nordisk’s diabetes drug in China

China Food and Drug Administration (CFDA) has approved Novo Nordisk’s Tresiba (insulin degludec) for the treatment of diabetes in China.

Posted in Approval, Asia, news, Regions | Tagged , , , | Leave a comment

Federal judge orders U.S. company to stop distributing unapproved drugs

FDA has reported that the federal judge ordered a New Jersey company that sold injectable skin whitening and other beauty products to stop selling and recall some of its products because they are unapproved new drugs that may be unsafe, putting consumers at risk.

Posted in news, North America, Regions | Tagged , , | Leave a comment

Novartis and The Max Foundation transform pioneering cancer access program for people in lower-income countries

Novartis has enterned in new collaboration with The Max Foundation to support continued access to treatment at no cost for nearly 34,000 current patients with chronic myeloid leukemia (CML), gastrointestinal tumors (GIST) and other rare cancers.

Posted in Europe, news, Regions | Tagged , , , , , | Leave a comment